2000 Cannabis Clinical Trials Microdosing 
Veriheal
MARCH 20, 2023
Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Johns Hopkins University first received regulatory approval for psychedelic research in the year 2000. appeared first on Cannabis Central.
Cannabis Law Report
JUNE 4, 2021
Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009.
Expert insights. Personalized for you.
98 
Let's personalize your content